BrainsWay Ltd.

NASDAQ:BWAY

Medical - Devices

Healthcare
$8.98 +0.35%

+$0.05 today

Market cap
$352.22M
Beta
0.15
P/E (TTM)
61.7
EPS (TTM)
$0.23
52W Low $5.42High $17.35

Volume 0.15M

Average 0.15M

BWAY Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

BrainsWay Ltd.NASDAQ: BWAY

Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Free cash flow dips below year-ago levels

Q1 FY2026 free cash flow of $402K fell 89.9% year over year, behind the +58.7% change in trailing-twelve-month free cash flow. Sequentially, it fell 22.5% from the prior quarter.

Context

  • Free cash flow amounted to 31.4% of revenue in FY2025, up 15.5 pp from a year earlier.
  • Free cash flow increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -89.9% toward the trailing-twelve-month pace of +58.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$402K-22.5% QoQ
Last fiscal yearDec 2025
$16.4M+152.2% YoY
LTMMar 2026
$12.72M+58.7% YoY
Free Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-89.9%——
1 year+152.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Free Cash Flow history

USD · from the cash flow

Latest · FY2025
16.4M USD
Year-over-year change
+152.2%

Free Cash Flow vs competitors

How BWAY compares with its peers on the latest reported figures

  • BWAY's LTM Mar 2026 free cash flow of $12.72M is the 3rd largest of the 4 companies compared; the peer median is $13.58M.
  • Its year-over-year change of +58.7% is the highest of 4, against a peer median of -45.8%.
  • Free cash flow amounts to 22.6% of revenue for BWAY, versus a peer median of 9.9%.
BWAY Competitors Peer median
Free Cash Flow for BWAY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HSDTSolana CompanyLTM Mar 2026$17.81M +53.8%+62.3%185.7%
STIMNeuronetics, Inc.LTM Mar 2026$13.58M -63.6%-14.6%9.0%
BWAYBrainsWay Ltd.LTM Mar 2026$12.72M +58.7%—22.6%
NPCENeuroPace, Inc.LTM Mar 2026$9.84M -45.8%-32.9%9.9%
MOBIMobia Medical, Inc. Common Stock—— ———
Peer median (excluding BWAY) $13.58M-45.8%-14.6%9.9%

Competitors are the stored peer set for BWAY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(6.46M)(13.35M)(4.2M)2.92M7.63M
Depreciation & Amortization1.69M1.53M1.34M1.77M1.54M
Deferred Income Tax43K315K251K538K77K
Stock-Based Compensation1.89M1.47M381K1.44M1.2M
Change in Working Capital1.07M(1.45M)1.64M2.39M8.23M
Accounts Receivables(849K)1.46M1.09M(867K)611.82K
Inventory(411K)(3.6M)(506K)(920K)(1.41M)
Accounts Payables289K0(327K)2.12M(480.78K)
Other Working Capital2.04M685K1.38M2.06M9.52M
Other Non-Cash Items2.66M1.72M1.88M1.24M(506.79K)
Operating Cash Flow884K(9.76M)1.28M10.3M18.16M
Capital Expenditures(2.24M)9.72M(2.39M)(3.79M)(1.76M)
Acquisitions (Net)39.98M0000
Purchases of Investments(40M)(21K)00(15.89M)
Sales of Investments22K40.25M0020.16K
Other Investing Activities(39.98M)0(35.02M)35.08M0
Investing Cash Flow(42.22M)42.17M(37.41M)30.31M(17.63M)
Debt Repayment(475K)(533K)(271K)(424K)(832K)
Common Stock Issued42.26M0016.35M0
Common Stock Repurchased0(52K)000
Dividends Paid00000
Other Financing Activities(269K)(962K)(755K)2.33M(1.4M)
Financing Cash Flow41.52M(1.55M)(1.03M)18.26M(2.23M)
Effect of Forex Changes(224K)(202K)90K(47K)34.35K
Net Change in Cash(40K)30.66M(37.06M)58.83M(1.67M)
Free Cash Flow(1.35M)(9.76M)(1.1M)6.5M16.4M

BrainsWay Ltd.

NASDAQ:BWAY

Intrinsic Alpha fair value

Locked

Current Price

$8.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.